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Abstract
Background: Pre-gestational and gestational diabetes mellitus are common complications in pregnancy affecting
one in six pregnancies. The maternity services are under significant strain managing the increasing number of
complex pregnancies. This has an impact on patients’ experience of antenatal care. Therefore, there is a clear need
to address pregnancy care. One possible solution is to use home-based digital technology to reduce clinic visits
and improve clinical monitoring.
Methods: The aim of this study was to evaluate the antenatal services provided to pregnant women with diabetes
who were monitored at the joint metabolic and obstetric clinic at the Southern Health and Social Care Trust in
Northern Ireland.
Results: The questionnaires were completed by sixty-three women, most of whom had gestational diabetes
mellitus. Most of the participants were between 25 and 35 years of age (69.8%), had one or more children (65.1%)
and spent over 2 h attending the clinics (63.9%); 78% of women indicated that their travel time to and from the
clinic appointment was over 15 min. Over 70% of women used smartphones for health-related purposes. However,
only 8.8% used smartphones to manage their health or diabetes. Less than 25% of the women surveyed expressed
concerns about using digital technology from home to monitor various aspects of their health in pregnancy.
Conclusions: Overall, pregnant women who had or developed diabetes in pregnancy experience frequent hospital
visits and long waiting times in the maternity clinics. Most of these pregnant women are willing to self-manage
their condition from home and to be monitored remotely by the healthcare staff.
Keywords: Pregnancy, Diabetes, Gestational diabetes, Type 1 diabetes, Type 2 diabetes, Antenatal clinic, Home
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Background
Hyperglycaemia is the most common complication in
pregnancy. It affects one in six pregnancies and it can
lead to a number of complications such as miscarriage,
still birth, pre-eclampsia, obstructed labour, increased
risk of caesarean section, pre-term birth and the devel-
opment of type 2 diabetes (T2D) in later life [1–3]. Dia-
betes in pregnancy includes pre-gestational diabetes,
namely type 1 diabetes mellitus (T1DM) or T2DM, and
gestational diabetes mellitus (GDM). GDM is defined as
glucose intolerance with onset and first recognition in
pregnancy [4]. The latest guidelines on the diagnosis of
GDM provided by the World Health Organization
(WHO, 2013) include the following parameters: fasting
blood glucose over 5.1 mmol/l (91.8 mg/dl), 1-h post-
prandial blood glucose above 10 mmol/l (180 mg/dl) and
2-h postprandial blood glucose of 8.5 mmol/l (153mg/
dl) [5]. However, there are notable differences between
individual hospitals and countries in screening and diag-
nosis of GDM [6].
Globally, over 21 million women are affected by some
form of hyperglycaemia in pregnancy; GDM accounting
for over 85% of these cases [7]. The vast majority of
these cases are in low and middle-income countries with
limited access to antenatal care. The increased incidence
of diabetes in pregnancy has also negatively affected the
healthcare services globally, which are struggling to meet
the demand of high and increased number of complex
pregnancies. Telehealth solutions have been proposed to
relieve the pressure on both pregnant women and the
health care service providers. However, to date, these
services offer no advantage over standard care [8, 9].
In this study, we carried out a service evaluation at the
Southern Health and Social Care (HSC) Trust, one of
five Trusts providing integrated health and social care
services in Northern Ireland (UK). The Southern HSC
Trust serves a population of over 400 pregnant women
with diabetes every year. The aim of this study was to
evaluate the service provided by this Trust, in relation to
the management of diabetes in pregnancy, and to inves-
tigate the willingness of women to adapt home monitor-
ing during pregnancy.
Methods
This study was conducted at the joint metabolic and obstet-
ric antenatal clinic within the Craigavon Area Hospital, part
of the Southern HSC Trust. The evaluation of the service
by pregnant women with diabetes undergoing standard dia-
betes care was performed over a 4-week period. The partic-
ipants were randomly selected from the hospital based
metabolic-obstetric outpatient clinic. The study protocol,
questionnaire and patient information leaflet were ap-
proved by the Research Manager, Consultants and the
Heads of Services at the Southern HSC Trust. This study
was carried out as Service Evaluation and the questionnaire
was clearly entitled as “Service Evaluation – Improving
Services for the Management of Diabetes in Pregnancy”.
The documentation (Information for the Participants and
Questionnaire) about the Service Evaluation was available
at clinics for those interested to voluntarily and anonym-
ously complete. Consent was Implied Consent in that those
who completed the questionnaire did so voluntarily and an-
onymously on the basis of the information provided with
the questionnaire. As this study was carried out as Service
Evaluation it did not require ethical approval or research
governance but the approval of the Heads of the
Departments facilitated by the Research Manager at the
Southern Health and Social Care Trust. This is according
to the National Research Ethics Service Guidelines pro-
duced by the NHS Health Research Authority [10].
Data collection: questionnaire
The questionnaire design (Supplementary file) was based
on the previous work conducted by several of the au-
thors (JG, CJW, JOD) to evaluate mHealth solutions.
The questionnaire was completed in between 5 and 10
min and contained closed questions suitable for service
evaluation purposes. The questionnaire consisted of 24
questions, including demographic descriptors, questions
designed to determine time spent attending the ante-
natal clinics, information on the use of smartphones or
tablets to manage health, acceptability of home monitor-
ing of various parameters during pregnancy and remote
management by the healthcare staff.
Data analysis
The questionnaires were manually entered onto the Sur-
vey Monkey website, US. The data was analysed using
the software integrated in the website.
Results
Seventy women were approached to take part in the
study. Seven women refused due to language barriers,
sixty-two women completed the questionnaire inde-
pendently and one participant was assisted by a clinic
interpreter.
Participants’ demographics and time spent on current
management of diabetes are presented in Table 1. The
vast majority of the participants were white Caucasian
between 25 and 35 years of age (69.8%), had one or more
children (65.1%), had GDM (68.2%) and spent over 2 h
attending the clinics (63.9%); 44.5% travelled for more
than 30min each way to the hospital.
Smartphones and tablets are widely used among the
participants; 93.5% of women were current users of
smartphones, with almost an even distribution between
iOS and Android users. The average time spent on using
these mobile devices was between 1 and 5 h per day
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(73.3%). Over 70% of women using smartphones were
already using the phones for health-related activities.
However, only 8.8% used the smartphones to manage
diabetes or health. Interestingly, around 40% of women
did not record their blood glucose results immediately
after measuring their blood glucose levels. Depending on
what they would be required to input and test, between
78 and 90% of women found it acceptable to use a
smartphone for managing their health in pregnancy.
Most of the participants had no concerns about using
smartphones or tablets in the context of managing their
health or pregnancy (75.8%). More than 80% of women
felt that it is acceptable to measure different clinical and
lifestyle parameters related to their health at home and
more than 60% of them are willing to discuss the results
with clinic staff remotely. However, 91% of the partici-
pants would like to receive video, written, or face-to-face
training. Further information from this survey is pre-
sented in Table 2.
Discussion
This study clearly demonstrates that there is a need for
more efficient management of diabetes in pregnancy.
The majority of women taking part in this study spent
more than 2 h every 1–2 weeks at the joint metabolic
and obstetric antenatal clinic; this excludes the time
spent getting to and from the clinic. According to the
National Institute for Clinical Excellence (NICE) guide-
lines, women with diabetes in pregnancy are required to
attend joint diabetic and obstetric clinics every 1–2
weeks from conception (T1DM and T2DM) or from
GDM diagnosis (around week 24–28) for assessment of










The number of children
None 34.9 22
1 30.2 19
2 or more 34.9 22
Education level
None 0 0
GCSE (school exit level)s 22.2 14





Type 1 diabetes 22.2 14
Type 2 diabetes 3.2 2
Gestational Diabetes 68.2 43
Other 1.6 1
Not sure 4.8 3






Length of time it takes to reach the clinic
Less than 15min 22.2 14
15–30 min 33.3 21
30–60 min 39.7 25
More than 60 min 4.8 3
Average waiting time in the clinic before first seeing
any of the maternity or diabetes team
Less than 15 min 11.1 7
15–30min 49.2 31
30–60min 25.4 16
More than 60 min 14.3 9
Average time spent in the clinic
Less than 30 min 3.3 2
30min −1 h 4.9 3
Table 1 Participants’ demographics and time spent on current
management of diabetes (Continued)
(%) Responses (n)
1–2 h 27.9 17
2–3 h 50.8 31
Greater than 3 h 13.1 8
Time typically spent on capturing each blood
glucose measurement using the current paper
based method every day
Less than 10 min 71.2 42
10–20min 22 13
20–30min 0 0
More than 30 min 6.8 4
Frequency of recording data in blood sugar monitoring diary
Each time you monitor a blood sugar level 59.3 35
At the end of the day 28.8 17
At weekends 1.7 1
At the end of the week 11.9 7
Prior to clinic 6.8 4
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blood glucose control and foetal growth [11]. Good gly-
caemic control in pregnant women with diabetes is key
and it reduces complications associated with this condi-
tion in pregnancy [12–15]. The evidence that remote
monitoring using digital technologies is acceptable to
pregnant women and superior to the standard of care is
limited [16–19]. A recent study using a remote blood
glucose monitoring system demonstrated safety, user
satisfaction and superior data capture. However, no dif-
ferences in the maternal glucose management were ob-
served, whereas pre-term births and caesarean deliveries
were less common in the intervention group using a mo-
bile-phone-based real-time blood glucose management
system [20]. There have been no health economic assess-
ments of this approach compared to usual care which
are important to consider in the future due to unprece-
dented increase in the number of women with diabetes
in pregnancy [7]. In a separate study, one of the authors
(CO) conducted a virtual clinic at the same joint meta-
bolic and obstetric antenatal clinic for pregnant women
with diabetes who did not require frequent obstetrics ap-
pointments. This method identified that, on average 6–8
women (10%) were suitable candidates for remote moni-
toring. These women are likely to be diagnosed with
GDM rather than more complex pregnancies in the
presence of T1DM or T2DM. In our study, most of the
women had GDM (68.2%), therefore, our findings are
more relevant to this population of pregnant women.
The growing number of women with diabetes in preg-
nancy, particularly GDM, is a significant burden for the
healthcare systems globally. Considering pregnant
women are generally motivated to self-monitor their
condition remotely and are smartphone literate, digital
technology for home monitoring provides an option for
this cohort of women. Nevertheless, glucose manage-
ment is often influenced by the obstetrics advice based
on the foetal growth, which if restricted, in some cases
requires admission to the hospital for steroid treatment.
These obstetrics requirements exclude certain pregnant
women for being suitable candidates for home monitor-
ing. As a result, identifying pregnant women who can be
safely monitored from home is a challenge that is influ-
enced by obstetrics’ need.
The need for real-time data collection is also clear
from this study. Indeed, only 60% of women record their
blood glucose results at the time of monitoring (Table
1). Further studies are required to determine the clinical
effectiveness of home monitoring interventions. None-
theless, a systematic review of mobile phone-based inter-
ventions with clinical feedback showed that they
improve glycaemic control (HbA1c) compared to stand-
ard care or other non-mHealth approaches by as much
as 0.8% for T2M patients and 0.3% for T1D patients over
the short-term (≤12months) [21]. This suggests a role
for these devices during pregnancy. The main limitation
of our study is the small sample size. Nevertheless our
findings confirm the general consensus amongst the
healthcare professionals and patients regarding the sig-
nificant strain on specialist diabetic maternity services,
Table 2 Details of the self-management of diabetes in
pregnancy
(%) Responses (n)
Current usage of the smartphones
Yes 93.5 95
No 6.4 4
Usage of the smartphones or tablets to obtain




Health related activities that participants use
their device(s) for
Electronic communication (email, chat, text
messages) with my doctor or midwife
45.6 26
Electronic communication with patient groups
(group text messages/ Facebook/WhatsApp etc.)
29.8 17
Electronic communication with other health care
providers
14 8
Finding doctors 3.5 2
Finding pharmacies 5.3 3
Managing my health data (blood sugar, heart
rate, blood pressure)
8.8 5
For obtaining information about symptoms and
conditions
66.7 38
For obtaining information about diagnostic and
therapeutic procedures
31.6 18
For finding my own diagnosis 26.3 15
For documenting and managing fitness related
data (e.g. using blood glucose meters, Fitbit etc.)
19.3 11
Other 14 8
Concerns in relation to using smartphones/
tablets in the context of managing their
health or pregnancy
None 75.8 47
Concerns about data security 17.7 11
Concerns about the technical reliability of the
devices
6.4 4
Concerns about the reliability of the software 9.7 6
The devices are too complicated to use 1.6 1
Not being able to attend as many hospital
appointments/other concerns
3.2 2




Not sure 19 12
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which often results in a poor patient experience. This
area of important research has not been quantified and
reported until now.
In this study, it was clear that women were not only
willing to manage blood glucose remotely but that they
were willing to monitor other health indicators during
pregnancy. Most of women do not have any concerns
about using digital technology to manage their health in
pregnancy and are willing to have video or telephone
conversations with the clinicians. The advantage of cap-
turing the data remotely and in real-time is that it may
increase data accuracy and reduces the time commit-
ment and stress of frequent clinical appointments.
Conclusions
Our service evaluation demonstrates that the self-man-
agement and home monitoring clearly appeals to preg-
nant women with diabetes and provides a good insight
into the antenatal care provided in the UK. This is the
first report that evaluates joint metabolic and obstetric
antenatal care from the patients’ perspective, particularly
focusing on the management of GDM. This study also
confirms the long waiting times at antenatal clinics and
willingness of this highly motivated group of patients to
self-manage their condition with remote support by the
healthcare staff.
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